Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic medicine through UCL Institute of Ophthalmology and Moorfields Eye Hospital, with ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...

The Congressional Review Act can axe costly Biden rules.

Colorado regulators have issued the first licenses to individuals looking to enter the state’s emerging psilocybin industry.

Telix is in a strong financial position with net cash of AUD 140 million as of December 2024. We forecast free cash flow averaging 87% of net income over the next 10 years, and in the absence of major ...

Evolving regulations link workplace conditions to mental health, driving corporate compliance and increasing investment.

X4 has entered an exclusive agreement with taiba rare for distributing and commercialising Xolremdi in select Middle Eastern ...

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell ...

Issued on behalf of Oncolytics Biotech Inc. "We're hitting critical milestones that validate our progress and set the stage for what we believe will be an exciting year," said Wayne Pisano, Interim ...

C3i became the first contract development and manufacturing organization (CDMO) for cell and gene therapies in Canada to ...